Submitted:
23 August 2026
Posted:
24 August 2026
You are already at the latest version
Abstract
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment for hematological malignancies but is associated with severe neurological complications. Although cerebrovascular events are relatively uncommon after allo-HSCT, with reported rates of 2–8%, they are difficult to manage and may substantially increase mortality. Their epidemiology, timing, risk factors, and influence on transplantation outcomes remain insufficiently characterized. This study aimed to assess the impact of post-transplant stroke on transplantation outcomes in patients with hematological malignancies.
Keywords:
complications of treatment of hematological diseases
; leukemia
; allogeneic transplantation
; long-term complications
; complications with a sequel
; stroke
; ischemic stroke
; hemorrhagic stroke
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.